What is the ticker symbol for Protara Therapeutics?

Protara Therapeutics trades under the ticker TARA on NASDAQ.

What sector does Protara Therapeutics operate in?

Protara Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze TARA in a portfolio?

PortView shows TARA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Protara Therapeutics (TARA) Stock Analysis

NASDAQHealthcareBiotechnology

$3.90-0.04%

1-year price historyRange $3.03 – $7.56

52-week range$3.90

$3.02$7.82

What Protara Therapeutics does

Protara Therapeutics, Inc. is a biotechnology company actively involved in clinical research and development, striving to identify and advance groundbreaking therapies. Their core mission is to tackle significant medical challenges in both oncology and rare disease domains. The company's leading therapeutic candidate, TARA-002, is an investigational cellular therapy currently under evaluation for the treatment of lymphatic malformations. Furthermore, Protara is developing intravenous choline chloride, a potential phospholipid substrate replacement therapy aimed at addressing liver disease associated with intestinal failure. The organization, which was formerly known as ArTara Therapeutics, Inc., underwent a name change to Protara Therapeutics, Inc. in May 2020. Its principal operations are based in New York, New York.

Key metrics

Market cap

$219.20M

P/E (TTM)

-2.91

EPS (TTM)

$-1.34

Beta

1.49

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$4.02

200-day avg

$5.16

52-week high

$7.82

52-week low

$3.02

CEO

Jesse Shefferman

ETFs linked to TARA

Broad-market and Healthcare sector ETFs an investor holding Protara Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how TARA fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze TARA in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Protara Therapeutics?: Protara Therapeutics trades under the ticker TARA on NASDAQ.
Which exchange is TARA listed on?: TARA is listed on NASDAQ.
What sector does Protara Therapeutics operate in?: Protara Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze TARA in a portfolio?: PortView shows TARA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.